Concurrent cisplatin and radiotherapy for inoperable bladder cancer: Long term results and prognostic predictors of local control and survival;Resultats a long terme du traitement des cancers de vessie inoperables par cisplatine et irradiation concomitante: Facteurs pronostiques du controle local et de la survie

Cancer/Radiotherapie

Volumn 2, Issue SUPPL. 1, 1998, Pages

  Chauvet, B ^a   Felix Faure, C ^a   Davin, J L ^a   Choquenet, C ^a   Alfonsi, M ^a   Reboul, F ^a  

^a INSTITUT SAINTE CATHERINE   (France)

Author keywords

Bladder cancer; Cisplatin; Organ preservation; Radiotherapy

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT; RADIOSENSITIZING AGENT;

AGED; BLADDER CANCER; CANCER CONTROL; CANCER STAGING; CONFERENCE PAPER; CONSERVATIVE TREATMENT; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; ORGAN PRESERVATION; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TRANSURETHRAL RESECTION; TREATMENT INDICATION; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLADDER TUMOR; CLINICAL TRIAL; FEMALE; MALE; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE; SURVIVAL; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 0032037887     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)